|
US3272824A
(en)
|
1962-12-06 |
1966-09-13 |
Norwich Pharma Co |
4-amino-6, 7-di(lower) alkoxyquinolines
|
|
US3266990A
(en)
|
1963-09-24 |
1966-08-16 |
Warner Lambert Pharmaceutical |
Derivatives of quinazoline
|
|
US3936461A
(en)
|
1973-09-24 |
1976-02-03 |
Warner-Lambert Company |
Substituted 4-benzylquinolines
|
|
US4114939A
(en)
|
1976-09-13 |
1978-09-19 |
Conco Inc. |
Vacuum pickup head
|
|
IL89029A
(en)
|
1988-01-29 |
1993-01-31 |
Lilly Co Eli |
Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
|
|
IL89027A
(en)
|
1988-01-29 |
1993-01-31 |
Lilly Co Eli |
Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
|
|
GT198900008A
(es)
|
1988-01-29 |
1990-07-17 |
|
Derivados de quinolina, quinazolina y cinolina.
|
|
WO1990005523A2
(en)
|
1988-11-15 |
1990-05-31 |
The Upjohn Company |
Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
|
|
US5034393A
(en)
*
|
1989-07-27 |
1991-07-23 |
Dowelanco |
Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
|
|
JPH0772176B2
(ja)
|
1991-04-03 |
1995-08-02 |
コリア リサーチ インスティチュート オブ ケミカル テクノロジイ |
２―キノリノン誘導体
|
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
|
JPH05213884A
(ja)
|
1991-06-14 |
1993-08-24 |
Upjohn Co:The |
新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
|
US5326766A
(en)
*
|
1992-08-19 |
1994-07-05 |
Dreikorn Barry A |
4-(2-(4-(2-pyridinyloxy)phenyl)ethoxy)quinazoline and analogues thereof
|
|
WO1994004527A1
(en)
|
1992-08-19 |
1994-03-03 |
Dowelanco |
Pyridylethoxy-, pyridylethylamino-, and pyridylpropyl-derivatives of quinoline and quinazoline as insecticides and fungicides
|
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9314884D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Tricyclic derivatives
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
GB9510757D0
(en)
|
1994-09-19 |
1995-07-19 |
Wellcome Found |
Therapeuticaly active compounds
|
|
WO1996040648A1
(en)
|
1995-06-07 |
1996-12-19 |
Sugen, Inc. |
Quinazolines and pharmaceutical compositions
|
|
US5650415A
(en)
|
1995-06-07 |
1997-07-22 |
Sugen, Inc. |
Quinoline compounds
|
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
|
AU7340096A
(en)
|
1995-11-07 |
1997-05-29 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
|
JP4471404B2
(ja)
|
1996-02-13 |
2010-06-02 |
アストラゼネカ ユーケイ リミテッド |
Ｖｅｇｆインヒビターとしてのキナゾリン誘導体
|
|
PT912559E
(pt)
|
1996-07-13 |
2003-03-31 |
Glaxo Group Ltd |
Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
|
|
WO1998013350A1
(en)
|
1996-09-25 |
1998-04-02 |
Zeneca Limited |
Qinoline derivatives inhibiting the effect of growth factors such as vegf
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
US6251912B1
(en)
|
1997-08-01 |
2001-06-26 |
American Cyanamid Company |
Substituted quinazoline derivatives
|
|
AU1631699A
(en)
|
1997-12-18 |
1999-07-05 |
E.I. Du Pont De Nemours And Company |
Cyclohexylamine arthropodicides and fungicides
|
|
WO2000005234A1
(en)
*
|
1998-07-22 |
2000-02-03 |
Suntory Limited |
NF-λB INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT
|
|
US6297258B1
(en)
|
1998-09-29 |
2001-10-02 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
CA2344290C
(en)
|
1998-10-08 |
2009-06-02 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US6797823B1
(en)
|
1999-01-22 |
2004-09-28 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives
|
|
IL144745A0
(en)
|
1999-02-10 |
2002-06-30 |
Astrazeneca Ab |
Quinazoline derivatives as angiogenesis inhibitors
|
|
GB9904103D0
(en)
|
1999-02-24 |
1999-04-14 |
Zeneca Ltd |
Quinoline derivatives
|
|
GB9910580D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
GB9910579D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
CN1391562A
(zh)
|
1999-09-21 |
2003-01-15 |
阿斯特拉曾尼卡有限公司 |
用作药物的喹唑啉衍生物
|
|
US7081461B1
(en)
|
1999-09-21 |
2006-07-25 |
Astrazeneca Ab |
Quinazoline compounds and pharmaceutical compositions containing them
|
|
GB9930061D0
(en)
|
1999-12-20 |
2000-02-09 |
Glaxo Group Ltd |
Quinolone compounds for use in treating viral infections
|
|
EP1243582A4
(en)
|
1999-12-24 |
2003-06-04 |
Kirin Brewery |
CHINOLINE AND CHINAZOLINE DERIVATIVES AND MEDICATIONS CONTAINING THEM
|
|
US6906063B2
(en)
|
2000-02-04 |
2005-06-14 |
Portola Pharmaceuticals, Inc. |
Platelet ADP receptor inhibitors
|
|
BR0109828A
(pt)
|
2000-04-07 |
2002-12-17 |
Astrazeneca Ab |
Composto, processo para a prepapação do mesmo ou de um sal deste, composição farmacêutica, uso do composto ou de um sal deste farmaceuticamente aceitável, e, método para a produção de um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente em necessidade de tal tratamento
|
|
CN1267431C
(zh)
|
2000-06-28 |
2006-08-02 |
阿斯特拉曾尼卡有限公司 |
取代的喹唑啉衍生物及其在制备作为抑制剂的药物中的用途
|
|
DE10042064A1
(de)
|
2000-08-26 |
2002-03-07 |
Boehringer Ingelheim Pharma |
Chinazoline, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
|
AU2002210714A1
(en)
|
2000-11-02 |
2002-06-11 |
Astrazeneca Ab |
Substituted quinolines as antitumor agents
|
|
EP1381599B1
(en)
|
2001-04-19 |
2008-09-24 |
Astrazeneca AB |
Quinazoline derivatives
|
|
PL209822B1
(pl)
|
2001-04-27 |
2011-10-31 |
Kirin Pharma Kk |
Pochodna chinoliny lub chinazoliny, zawierająca ją kompozycja farmaceutyczna i zastosowanie
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
DE60233736D1
(de)
|
2001-06-22 |
2009-10-29 |
Kirin Pharma K K |
Chinolinderivat und chinazolinderivat, die die selbstphosphorylierung des hepatocytus-proliferator-rezeptors hemmen, und diese enthaltende medizinische zusammensetzung
|
|
ATE341545T1
(de)
|
2001-07-16 |
2006-10-15 |
Astrazeneca Ab |
Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase
|
|
WO2003033472A1
(en)
|
2001-10-17 |
2003-04-24 |
Kirin Beer Kabushiki Kaisha |
Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
|
|
WO2003045920A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
|
AU2002347336A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Quinoline derivatives
|
|
AU2002365664A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Quinoline derivatives as antitumour agents
|
|
AU2002365665A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours
|
|
GB0129099D0
(en)
|
2001-12-05 |
2002-01-23 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2003047584A1
(en)
|
2001-12-05 |
2003-06-12 |
Astrazeneca Ab |
Quinoline derivatives
|
|
AU2002347360A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours
|
|
AU2002361846A1
(en)
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
ES2381781T3
(es)
|
2002-02-01 |
2012-05-31 |
Astrazeneca Ab |
Compuestos de quinazolina
|
|
AU2003235838A1
(en)
|
2002-05-01 |
2003-11-17 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
|
|
DE10221018A1
(de)
|
2002-05-11 |
2003-11-27 |
Boehringer Ingelheim Pharma |
Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
DE60327323D1
(de)
|
2002-07-09 |
2009-06-04 |
Astrazeneca Ab |
Chinazoline derivative und ihre anwendung in der krebsbehandlung
|
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
ES2400339T3
(es)
|
2002-07-15 |
2013-04-09 |
Symphony Evolution, Inc. |
Compuestos, composiciones farmacéuticas de los mismos y su uso en el tratamiento del cáncer
|
|
AU2003257666A1
(en)
|
2002-08-23 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
|
|
AU2003280599A1
(en)
|
2002-10-29 |
2004-05-25 |
Kirin Beer Kabushiki Kaisha |
QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
|
|
GB0225579D0
(en)
|
2002-11-02 |
2002-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
DK1562955T3
(da)
|
2002-11-04 |
2008-06-02 |
Astrazeneca Ab |
Quinazolinderivater som Src-tyrosinkinaseinhibitorer
|
|
PA8603801A1
(es)
|
2003-05-27 |
2004-12-16 |
Janssen Pharmaceutica Nv |
Derivados de la quinazolina
|
|
WO2004111014A1
(en)
*
|
2003-06-06 |
2004-12-23 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
CN1838950A
(zh)
*
|
2003-06-23 |
2006-09-27 |
神经化学（国际）有限公司 |
治疗蛋白质聚集疾病的方法
|
|
US20050026805A1
(en)
|
2003-07-14 |
2005-02-03 |
Ici Americas, Inc. |
Solvated nonionic surfactants and fatty acids
|
|
GB0318422D0
(en)
|
2003-08-06 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
KR101158440B1
(ko)
|
2003-12-18 |
2012-07-06 |
얀센 파마슈티카 엔.브이. |
항증식활성을 지닌 3-시아노-퀴놀린 유도체
|
|
NZ547794A
(en)
|
2003-12-18 |
2009-11-27 |
Janssen Pharmaceutica Nv |
Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents
|
|
WO2005063739A1
(en)
|
2003-12-23 |
2005-07-14 |
Pfizer Inc. |
Novel quinoline derivatives
|
|
CN1930128A
(zh)
|
2004-01-16 |
2007-03-14 |
惠氏公司 |
受体酪氨酸激酶抑制剂的喹啉中间体及其合成
|
|
RU2414457C2
(ru)
|
2005-02-23 |
2011-03-20 |
Сионоги Энд Ко., Лтд. |
Производные хиназолина, обладающие ингибирующей активностью в отношении тирозинкиназы
|
|
CN101115736A
(zh)
*
|
2005-03-14 |
2008-01-30 |
神经研究公司 |
钾通道调节剂和它们的医药用途
|
|
NZ556248A
(en)
*
|
2005-03-14 |
2010-06-25 |
Neurosearch As |
Pyrazolyl-quinazoline potassium channel modulating agents and their medical use
|
|
CA2603748A1
(en)
|
2005-04-06 |
2006-10-12 |
Exelixis, Inc. |
C-met modulators and methods of use
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
US20090221624A1
(en)
|
2005-05-06 |
2009-09-03 |
Olivo Paul D |
4-aminoquinoline compounds for treating virus-related conditions
|
|
US20090053236A1
(en)
|
2005-11-07 |
2009-02-26 |
Eisai R & D Management Co., Ltd. |
USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR
|
|
WO2007055513A1
(en)
|
2005-11-08 |
2007-05-18 |
Hanmi Pharm. Co., Ltd. |
Quinazoline derivatives as a signal transduction inhibitor and method for the preparation thereof
|
|
JP5688877B2
(ja)
|
2005-11-11 |
2015-03-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
癌疾患の治療用キナゾリン誘導体
|
|
CN102702194A
(zh)
|
2005-12-21 |
2012-10-03 |
雅培制药有限公司 |
抗病毒化合物
|
|
ES2397181T3
(es)
|
2006-01-26 |
2013-03-05 |
Boehringer Ingelheim International Gmbh |
Procedimiento para preparar derivados de quinazolina sustituida con aminocrotonilamino
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
KR20150004441A
(ko)
|
2006-07-07 |
2015-01-12 |
칼립시스, 인코포레이티드 |
Ｐｄｅ４의 바이사이클릭 헤테로아릴 억제제
|
|
WO2008009077A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
|
JP2010501570A
(ja)
|
2006-08-23 |
2010-01-21 |
エックスティーエル バイオファーマシューティカルズ リミテッド |
４−チオ置換キノリンおよびナフチリジン化合物
|
|
CN101553490A
(zh)
*
|
2006-10-23 |
2009-10-07 |
Sgx药品公司 |
用作蛋白激酶调节剂的二环三唑类化合物
|
|
US8314087B2
(en)
|
2007-02-16 |
2012-11-20 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and methods of use
|
|
US8163923B2
(en)
|
2007-03-14 |
2012-04-24 |
Advenchen Laboratories, Llc |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US8148532B2
(en)
|
2007-03-14 |
2012-04-03 |
Guoqing Paul Chen |
Spiro substituted compounds as angiogenesis inhibitors
|
|
DE102007032739A1
(de)
|
2007-07-13 |
2009-01-15 |
Merck Patent Gmbh |
Chinazolinamidderivate
|
|
US8143276B2
(en)
|
2007-08-22 |
2012-03-27 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
|
MX2009014235A
(es)
|
2007-08-22 |
2010-04-27 |
Abbott Gmbh & Co Kg |
4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
|
|
AP2886A
(en)
|
2008-01-18 |
2014-05-31 |
Natco Pharma Ltd |
6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
|
|
WO2009148659A2
(en)
|
2008-03-05 |
2009-12-10 |
Georgetown University |
Antimalarial quinolines and methods of use thereof
|
|
NZ587907A
(en)
|
2008-03-17 |
2012-09-28 |
Ambit Biosciences Corp |
Quinazoline derivatives as RAF kinase modulators and methods of use thereof
|
|
US7829574B2
(en)
|
2008-05-09 |
2010-11-09 |
Hutchison Medipharma Enterprises Limited |
Substituted quinazoline compounds and their use in treating angiogenesis-related diseases
|
|
CA2727103A1
(en)
|
2008-07-03 |
2010-01-07 |
Merck Patent Gmbh |
Naphthyridinones as aurora kinase inhibitors
|
|
WO2010018555A2
(en)
|
2008-08-14 |
2010-02-18 |
University Of Cape Town |
Quinoline compounds containing a dibemethin group
|
|
WO2010025451A2
(en)
|
2008-08-29 |
2010-03-04 |
Dow Agrosciences Llc |
5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
|
|
IT1393351B1
(it)
|
2009-03-16 |
2012-04-20 |
Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa |
Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi
|
|
WO2010107965A1
(en)
|
2009-03-19 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Process for preparing sulfonyl quinolines
|
|
EP2408300B1
(en)
|
2009-03-21 |
2016-05-11 |
Sunshine Lake Pharma Co., Ltd. |
Amino ester derivatives, salts thereof and methods of use
|
|
ES2353093B1
(es)
*
|
2009-05-20 |
2012-01-03 |
Consejo Superior De Investigaciones Científicas (Csic) |
Uso de derivados de quinazolinas y sus composiciones farmacéuticas en enfermedades neurodegenerativas.
|
|
MX2011013666A
(es)
|
2009-06-25 |
2012-03-06 |
Amgen Inc |
Compuestos heterociclicos y sus usos.
|
|
PH12012500097A1
(en)
*
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
WO2011014039A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Rohm And Haas Electronic Materials Korea Ltd. |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
|
SG181976A1
(en)
|
2010-01-04 |
2012-08-30 |
Nippon Soda Co |
Nitrogen-containing heterocyclic compound and agricultural fungicide
|
|
US8575203B2
(en)
|
2010-04-21 |
2013-11-05 |
Boehringer Ingelheim International Gmbh |
Chemical compounds
|
|
WO2011143444A2
(en)
|
2010-05-14 |
2011-11-17 |
President And Fellows Of Harvard College |
Diphenylbutypiperidine autophagy inducers
|
|
AU2011271462A1
(en)
|
2010-06-30 |
2013-01-10 |
Amgen Inc. |
Nitrogen containing heterocyclic compounds as PIK3 -delta inhibitors
|
|
US20120015942A1
(en)
*
|
2010-07-19 |
2012-01-19 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
|
UY33549A
(es)
|
2010-08-10 |
2012-01-31 |
Glaxo Group Ltd |
Quinolil aminas como agentes inhibidores de las quinasas
|
|
WO2012044993A1
(en)
*
|
2010-09-30 |
2012-04-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
|
|
JP2014503528A
(ja)
*
|
2010-12-14 |
2014-02-13 |
エレクトロプホレトイクス リミテッド |
カゼインキナーゼ１δ（ＣＫ１δ）阻害剤及びタウオパチーなどの神経変性疾患の治療におけるその使用
|
|
WO2012090179A2
(en)
*
|
2010-12-30 |
2012-07-05 |
Lupin Limited |
Isoquinoline derivatives as cannabinoid receptor modulators
|
|
WO2012122011A2
(en)
|
2011-03-04 |
2012-09-13 |
Glaxosmithkline Llc |
Amino-quinolines as kinase inhibitors
|
|
US8664230B2
(en)
|
2011-03-17 |
2014-03-04 |
The Asan Foundation |
Pyridopyrimidine derivatives and use thereof
|
|
ITMI20110480A1
(it)
|
2011-03-25 |
2012-09-26 |
F I S Fabbrica Italiana Sint P A |
Procedimento per la preparazione di lapatinib e suoi sali
|
|
WO2013012915A1
(en)
*
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103958497B
(zh)
|
2011-11-14 |
2017-09-01 |
亚尼塔公司 |
作为AXL和c‑MET激酶抑制剂的尿嘧啶衍生物
|
|
CN102643268B
(zh)
|
2011-12-30 |
2014-05-21 |
沈阳药科大学 |
喹啉类及噌啉类化合物及其应用
|
|
AU2013237226A1
(en)
|
2012-03-19 |
2014-10-09 |
Emory University |
Quinazoline compounds and their use in therapy
|
|
EP2752413B1
(en)
|
2012-03-26 |
2016-03-23 |
Fujian Institute Of Research On The Structure Of Matter, Chinese Academy Of Sciences |
Quinazoline derivative and application thereof
|
|
TW201425307A
(zh)
|
2012-09-13 |
2014-07-01 |
Glaxosmithkline Llc |
作為激酶抑制劑之胺基－喹啉類
|
|
US9024023B2
(en)
|
2013-01-14 |
2015-05-05 |
F.I.S.—Fabbrica Italiana Sintetici S.p.A. |
Efficient process for the preparation of lapatinib and salts thereof by means of new intermediates
|
|
HK1217092A1
(zh)
|
2013-02-15 |
2016-12-23 |
Kala Pharmaceuticals, Inc. |
治疗性化合物及其用途
|
|
BR112015023222A2
(pt)
|
2013-03-15 |
2017-07-18 |
Rexahn Pharmaceuticals Inc |
compostos tetraidroisoquinolin-2-il-(quinazolin-4-il)metanona como inibidores do crescimento de células cancerosas
|
|
CN103232401B
(zh)
*
|
2013-04-12 |
2015-11-04 |
浙江工业大学 |
一种4-芳硫基喹唑啉类化合物的合成方法
|
|
US20160101106A1
(en)
|
2013-05-07 |
2016-04-14 |
Inhibikase Therapeutics, Inc. |
Methods for treating hcv infection
|
|
KR102240158B1
(ko)
|
2013-05-13 |
2021-04-15 |
샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 |
사이클로알킬산 유도체, 그의 제조 방법, 및 그의 약학적 용도
|
|
US9771333B2
(en)
|
2013-11-20 |
2017-09-26 |
Signalchem Lifesciences Corp. |
Quinazoline derivatives as TAM family kinase inhibitors
|
|
GB201321126D0
(en)
|
2013-11-29 |
2014-01-15 |
Velgene Biotechnology |
Autophagy stimulants
|
|
GB201321146D0
(en)
|
2013-11-29 |
2014-01-15 |
Cancer Rec Tech Ltd |
Quinazoline compounds
|
|
EP3091984B1
(en)
*
|
2014-01-09 |
2020-04-22 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Substituted benzoxazine and related compounds
|
|
AU2015237050B2
(en)
|
2014-03-24 |
2019-05-09 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd |
Quinoline derivatives as SMO inhibitors
|
|
FR3019819B1
(fr)
|
2014-04-09 |
2018-03-23 |
Centre National De La Recherche Scientifique (Cnrs) |
Composes cytotoxiques inhibiteurs de la polymerisation de la tubuline
|
|
EP3134091A4
(en)
|
2014-04-22 |
2017-08-30 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
CN104193728A
(zh)
*
|
2014-08-26 |
2014-12-10 |
北京大学深圳研究生院 |
流感病毒抑制剂及其应用
|
|
WO2017062500A2
(en)
*
|
2015-10-05 |
2017-04-13 |
The Trustees Of Columbia University In The City Of New York |
Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
|
|
US9853396B1
(en)
|
2016-12-05 |
2017-12-26 |
Delphi Technologies, Inc. |
Electrical plug having a flexible terminal retention feature
|